AEON Biopharma, Inc. (AEON) — Financial Flexibility Index
AEON Biopharma, Inc. (AEON) has a Financial Flexibility Index of -0.09x as of September 2025. Free cash flow of $-2.60 Million (operating CF $-2.60 Million minus capex $0.00) represents 0% of total liabilities ($28.61 Million). Also explore AEON Biopharma, Inc. annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
AEON Biopharma, Inc. Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for AEON Biopharma, Inc. across 6 annual periods. For the full cash flow conversion analysis, see AEON Biopharma, Inc. operating cash flow efficiency.
Annual Financial Flexibility Index for AEON Biopharma, Inc. (2019–2024)
Year-by-year free cash flow to debt coverage for AEON Biopharma, Inc.. Explore AEON cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.64x | $-20.29 Million | $-20.29 Million | $31.71 Million | ▼ -113.9% |
| 2023 | -0.30x | $-47.83 Million | $-47.83 Million | $159.89 Million | ▼ -138.4% |
| 2022 | -0.13x | $-35.28 Million | $-35.58 Million | $281.19 Million | ▼ -2.2% |
| 2021 | -0.12x | $-28.26 Million | $-28.43 Million | $230.26 Million | ▼ -196.5% |
| 2020 | -0.04x | $-9.29 Million | $-9.46 Million | $224.45 Million | ▲ +82.7% |
| 2019 | -0.24x | $-43.03 Million | $-44.73 Million | $180.22 Million | — |